Joseph Lewnard, PhD

Assistant Professor
University of California Berkeley

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-604) Preliminary real-world Abrysvo vaccine effectiveness (VE) against Respiratory Syncytial Virus (RSV)-related lower respiratory tract disease (LRTD) hospitalizations and emergency department (ED) visits—Kaiser Permanente of Southern California (KPSC), November 2023-April 2024
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT